NCT03481998 2023-11-21A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast CancerJiangsu HengRui Medicine Co., Ltd.Phase 1/2 Completed104 enrolled